MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/curroncol33060327

Медицинская библиотека · Current oncology (Toronto, Ont.) · 2026

Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.

Meagher Margaret F, Birouty Natalie, Musso Giacomo, Patil Dattatraya, Saito Kazutaka, Yasuda Yosuke, Puri Dhruv, Baker Benjamin, Yuen Kit, Roberts Jacob L, Ahdoot Aaron, Baker Omer, Dabbas Mai, Cortes Julian, Fujii Yasuhisa, Master Viraj, Liss Michael, Derweesh Ithaar H

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

Objective

This study aimed to investigate the impact of elevated CRP on survival outcomes in small renal masses (SRM).

Methods

This was a multi-institutional retrospective analysis of SRM (≤3 cm) managed surgically. The cohort was divided into elevated CRP (≥0.5 mg/dL) vs. non-elevated CRP groups (<0.5). The primary outcome was all-cause mortality (ACM). The secondary outcomes were non-cancer (NCM) and cancer-specific mortality (CSM). Cox-regression analysis was used to elucidate predictive factors for mortality outcomes. Kaplan-Meier Analysis (KMA) was performed to analyze 10-year overall (OS), cancer-specific (CSS) and non-cancer-specific survival (NCS).

Results

A total of 1001 patients were analyzed (309 non-elevated CRP/692 elevated CRP; median follow-up 70 months). Elevated CRP was an independent predictor for ACM (HR = 2.60, p < 0.001) NCM (HR = 2.90, p = 0.002), and CSM (HR = 1.20, p = 0.011). KMA comparing elevated vs. non-elevated groups revealed greater 10-year OS (p < 0.001) and NCS (p < 0.001) for non-elevated CRP, but no significant difference in 10-year CSS (p = 0.295). A total of 83 deaths were observed in elevated CRP (71 NCM/12 CSM-all clear-cell histology). The sensitivity/specificity of elevated CRP was 0.87/0.33, 0.75/0.81, and 0.90/0.33 for ACM, CSM, and NCM. By utilizing CRP for a decision-making algorithm prioritizing biopsy in CRP elevation and offering surveillance in benign or indolent histology, surgery may be avoided in 218 patients, in whom there were 38 fatalities, all NCM.

Conclusions

Elevated CRP was an independent predictor of survival outcomes in SRM ≤ 3 cm. From a competing mortality standpoint, patients with elevated CRP had significantly worsened NCM compared to CSM. In such patients, upfront oncologic risk stratification through biopsy may be considered, and indolent/low-grade neoplasms should be strongly considered for non-surgical management.

Для цитирования: Meagher Margaret F, Birouty Natalie, Musso Giacomo, Patil Dattatraya, Saito Kazutaka, Yasuda Yosuke, Puri Dhruv, Baker Benjamin, Yuen Kit, Roberts Jacob L, Ahdoot Aaron, Baker Omer, Dabbas Mai, Cortes Julian, Fujii Yasuhisa, Master Viraj, Liss Michael, Derweesh Ithaar H. Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.. Current oncology (Toronto, Ont.). 2026. DOI: 10.3390/curroncol33060327.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.